The purpose of this discussion is to provide an understanding of P&G’s financial results and condition by focusing on changes in certain key measures from year to year. Management's Discussion and Analysis (MD&A) is organized in the following sections:
· Overview
· Summary of Results
· Forward-Looking Statements
· Results of Operations - Three Months Ended March 31, 2007
· Results of Operations - Nine Months Ended March 31, 2007
· Business Segment Discussion - Three and Nine Months Ended March 31, 2007
· Financial Condition
· Reconciliation of Non-GAAP Measures
Throughout MD&A, we refer to measures used by management to evaluate performance including unit volume growth, net sales and net earnings. We also refer to organic sales growth (net sales growth excluding the impacts of acquisitions, divestitures and foreign exchange), free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates.
On October 1, 2005, we completed the acquisition of The Gillette Company for $53.43 billion. Gillette is a leading consumer products company that had $10.48 billion of sales in its most recent pre-acquisition year ended December 31, 2004. In order to provide our investors with more insight into the results of the Blades and Razors and the Duracell and Braun reporting segments, we have previously provided supplemental pro forma net sales and earnings data for these segments for the quarter ended September 30, 2005 (as presented in our Form 8-K released November 22, 2005). Management’s discussion of the current year to date results of these two reportable segments is in relation to the comparable prior year results, including pro forma net sales and earnings data for the July - September 2005 period and reported results for the October 2005 - March 2006 period. Results of Gillette’s personal care and oral care businesses were subsumed within the Beauty and the Health Care reportable segments, respectively.
OVERVIEW
P&G's business is focused on providing branded consumer goods products. Our goal is to provide products of superior quality and value to improve the lives of the world's consumers. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper.
Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We have also expanded our presence in "high frequency stores," the neighborhood stores which serve many consumers in developing markets. We compete in multiple product categories and have three global business units (GBUs): Beauty and Health; Household Care; and Gillette GBU. Under U.S. Generally Accepted Accounting Principles, the business units comprising the GBUs are aggregated into seven reportable segments: Beauty; Health Care; Fabric Care and Home Care; Baby Care and Family Care; Snacks, Coffee and Pet Care; Blades and Razors; and Duracell and Braun. We have on-the-ground operations in over 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas comprised of three developed regions (North America, Western Europe and Northeast Asia) and four developing regions (Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India).
The following table provides the percentage of net sales and net earnings by reportable business segment for the three months ended March 31, 2007 (excludes net sales and net earnings in Corporate):
| Net Sales | | Net Earnings |
Beauty and Health | 41% | | 43% |
Beauty | 30% | | 30% |
Health Care | 11% | | 13% |
| | | |
Household Care | 48% | | 45% |
Fabric Care and Home Care | 25% | | 26% |
Baby Care and Family Care | 17% | | 15% |
Snacks, Coffee and Pet Care | 6% | | 4% |
| | | |
Gillette GBU | 11% | | 12% |
Blades and Razors | 7% | | 11% |
Duracell and Braun | 4% | | 1% |
| | | |
Total | 100% | | 100% |
The following table provides the percentage of net sales and net earnings by reportable business segment for the nine months ended March 31, 2007 (excludes net sales and net earnings in Corporate):
| Net Sales | | Net Earnings |
Beauty and Health | 42% | | 45% |
Beauty | 30% | | 31% |
Health Care | 12% | | 14% |
| | | |
Household Care | 46% | | 40% |
Fabric Care and Home Care | 24% | | 24% |
Baby Care and Family Care | 16% | | 12% |
Snacks, Coffee and Pet Care | 6% | | 4% |
| | | |
Gillette GBU | 12% | | 15% |
Blades and Razors | 7% | | 11% |
Duracell and Braun | 5% | | 4% |
| | | |
Total | 100% | | 100% |
SUMMARY OF RESULTS
Following are highlights of results for the nine months ended March 31, 2007:
· Net sales grew 14 percent to $57.20 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, increased six percent.
· Unit volume increased 11 percent fiscal year to date including an additional three months of Gillette results in the current fiscal year period. Organic volume, which excludes the impacts of acquisitions and divestitures, was up five percent with every reportable segment delivering year-on-year organic volume growth.
· Net earnings increased 19 percent to $8.07 billion. Net earnings increased behind sales growth, the addition of Gillette and operating profit margin improvement.
· Diluted net earnings per share were $2.37, an increase of 13 percent versus the comparable prior year period.
· Operating cash flow was $9.85 billion, an increase of 20 percent versus the prior year period. Free cash flow productivity was 97 percent. Free cash flow productivity is defined as the ratio of operating cash flow less capital expenditures to net earnings.
FORWARD-LOOKING STATEMENTS
We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are "forward-looking statements," and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could be significantly different from our expectations.
Ability to Achieve Business Plans. We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives and trade terms. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. Since our goals include a growth component tied to acquisitions, we must manage and integrate key acquisitions, such as the Gillette and Wella acquisitions, including achieving the cost and growth synergies in accordance with stated goals.
Cost Pressures. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and work force rationalization.
Global Economic Conditions. Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend in part on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities.
Regulatory Environment. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent and intellectual property matters as well as those related to the integration of Gillette and its subsidiaries) and to resolve pending matters within current estimates may impact our results.
RESULTS OF OPERATIONS - Three Months Ended March 31, 2007
The following discussion provides a review of results for the three months ended March 31, 2007 versus the three months ended March 31, 2006.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information | |
| | Three Months Ended March 31 | | | |
| | 2007 | | 2006 | | % CHG | |
NET SALES | | $ | 18,694 | | $ | 17,250 | | | 8 | % |
COST OF PRODUCTS SOLD | | | 9,057 | | | 8,340 | | | 9 | % |
GROSS MARGIN | | | 9,637 | | | 8,910 | | | 8 | % |
SELLING, GENERAL & ADMINISTRATIVE EXPENSE | | | 5,991 | | | 5,559 | | | 8 | % |
OPERATING INCOME | | | 3,646 | | | 3,351 | | | 9 | % |
TOTAL INTEREST EXPENSE | | | 279 | | | 301 | | | | |
OTHER NON-OPERATING INCOME, NET | | | 169 | | | 79 | | | | |
EARNINGS BEFORE INCOME TAXES | | | 3,536 | | | 3,129 | | | 13 | % |
INCOME TAXES | | | 1,024 | | | 918 | | | | |
| | | | | | | | | | |
NET EARNINGS | | | 2,512 | | | 2,211 | | | 14 | % |
| | | | | | | | | | |
EFFECTIVE TAX RATE | | | 29.0 | % | | 29.3 | % | | | |
| | | | | | | | | | |
| | | | | | | | | | |
PER COMMON SHARE: | | | | | | | | | | |
BASIC NET EARNINGS | | $ | 0.78 | | $ | 0.67 | | | 16 | % |
DILUTED NET EARNINGS | | $ | 0.74 | | $ | 0.63 | | | 17 | % |
DIVIDENDS | | $ | 0.31 | | $ | 0.28 | | | 11 | % |
AVERAGE DILUTED SHARES OUTSTANDING | | | 3,397.3 | | | 3,510.5 | | | | |
| | | | | | | | | | |
COMPARISONS AS A % OF NET SALES | | | | | | | | | | |
COST OF PRODUCTS SOLD | | | 48.4 | % | | 48.3 | % | | 10 | |
GROSS MARGIN | | | 51.6 | % | | 51.7 | % | | (10 | ) |
S SELLING, GENERAL & ADMINISTRATIVE EXPENSE | | | 32.0 | % | | 32.2 | % | | (20 | ) |
OPERATING MARGIN | | | 19.5 | % | | 19.4 | % | | 10 | |
EARNINGS BEFORE INCOME TAXES | | | 18.9 | % | | 18.1 | % | | 80 | |
NET EARNINGS | | | 13.4 | % | | 12.8 | % | | 60 | |
Net sales for the quarter were up eight percent to $18.69 billion. All reportable segments except the Snacks, Coffee and Pet Care segment grew sales in the quarter, led by double-digit growth in Fabric Care and Home Care, Health Care and Baby Care and Family Care. Volume increased six percent with each geographic region delivering year-on-year growth, led by double-digit growth in developing regions. Organic volume also increased six percent behind high single-digit growth in Fabric Care and Home Care and Baby Care and Family Care, with declining volume in Snacks, Coffee and Pet Care. Tide, Ariel, Downy, Charmin, Head & Shoulders, Olay, Always and Prilosec OTC each posted double-digit volume growth in the quarter. Price increases across most of our reportable segments contributed one percent to sales growth but were offset by a negative one percent mix impact from a less premium product mix across several segments and disproportionate growth in developing regions, where selling prices are below the Company average. Foreign exchange added an additional two percent to sales growth. Organic sales increased six percent during the quarter.
| Net Sales Change Drivers 2007 vs. 2006 (Three Months Ended March 31) |
| Volume with Acquisitions & Divestitures | Volume excluding Acquisitions & Divestitures | Foreign Exchange | Price | Mix/ Other | Net Sales Growth | Net Sales Growth ex-FX |
Beauty and Health | | | | | | | |
Beauty | 3% | 4% | 3% | 1% | 1% | 8% | 5% |
Health Care | 6% | 6% | 2% | 1% | 1% | 10% | 8% |
Household Care | | | | | | | |
Fabric Care and Home Care | 10% | 9% | 2% | 0% | 0% | 12% | 10% |
Baby Care and Family Care | 8% | 8% | 3% | 1% | (2)% | 10% | 7% |
Snacks, Coffee and Pet Care | (2)% | (2)% | 1% | 3% | (2)% | 0% | (1)% |
Gillette GBU | | | | | | | |
Blades and Razors | 4% | 4% | 4% | 2% | (2)% | 8% | 4% |
Duracell and Braun | 0% | 3% | 3% | 2% | (2)% | 3% | 0% |
Total Company | 6% | 6% | 2% | 1% | (1)% | 8% | 6% |
Sales percentage changes are approximations based on quantitative formulas that are consistently applied.
Gross margin was down 10-basis points in the quarter to 51.6% of net sales. Commodity cost increases had a negative impact on gross margin of approximately 50-basis points but were more than offset by scale leverage from volume growth, price increases and cost savings projects. A number of one-time items during the quarter, including net charges related to the integration of Gillette, supply chain restructuring projects and the impacts of a pet food recall, reduced gross margin versus the prior year period by approximately 50-basis points.
Total selling, general and administrative expenses (SG&A) increased eight percent, or $432 million, during the quarter. Total SG&A as a percentage of net sales was down 20-basis points, primarily behind overhead spending during the quarter, partially offset by the impact of a favorable legal settlement in the year-ago period. Overhead spending as a percentage of net sales was down primarily due to volume scale leverage, overhead cost controls and Gillette synergy savings.
Interest expense for the quarter decreased by $22 million versus the year-ago period primarily due to lower gross debt. Other non-operating income was up $90 million year-on-year. The increase was primarily due to the gains on certain minor Beauty brand divestitures which closed during the quarter.
Net earnings increased 14 percent to $2.51 billion behind sales growth and profit margin expansion. Diluted net earnings per share were $0.74, up 17 percent versus the prior year. Earnings per share growth exceeded net earnings growth due to share repurchases, primarily under the $20.1 billion share buyback program in connection with the Gillette acquisition, which was completed in July 2006.
RESULTS OF OPERATIONS - Nine Months Ended March 31, 2007
The following discussion provides a review of results for the nine months ended March 31, 2007 versus the nine months ended March 31, 2006.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information | |
| | Nine Months Ended March 31 | |
| | 2007 | | 2006 | | % CHG | |
NET SALES | | $ | 57,204 | | $ | 50,380 | | | 14 | % |
COST OF PRODUCTS SOLD | | | 27,210 | | | 24,231 | | | 12 | % |
GROSS MARGIN | | | 29,994 | | | 26,149 | | | 15 | % |
SELLING, GENERAL & ADMINISTRATIVE EXPENSE | | | 17,945 | | | 15,849 | | | 13 | % |
OPERATING INCOME | | | 12,049 | | | 10,300 | | | 17 | % |
TOTAL INTEREST EXPENSE | | | 976 | | | 819 | | | | |
OTHER NON-OPERATING INCOME, NET | | | 429 | | | 221 | | | | |
EARNINGS BEFORE INCOME TAXES | | | 11,502 | | | 9,702 | | | 19 | % |
INCOME TAXES | | | 3,430 | | | 2,916 | | | | |
| | | | | | | | | | |
NET EARNINGS | | | 8,072 | | | 6,786 | | | 19 | % |
| | | | | | | | | | |
EFFECTIVE TAX RATE | | | 29.8 | % | | 30.1 | % | | | |
| | | | | | | | | | |
| | | | | | | | | | |
PER COMMON SHARE: | | | | | | | | | | |
BASIC NET EARNINGS | | $ | 2.51 | | $ | 2.22 | | | 13 | % |
DILUTED NET EARNINGS | | $ | 2.37 | | $ | 2.10 | | | 13 | % |
DIVIDENDS | | $ | 0.93 | | $ | 0.84 | | | 11 | % |
AVERAGE DILUTED SHARES OUTSTANDING | | | 3,405.7 | | | 3,235.4 | | | | |
| | | | | | | | | | |
COMPARISONS AS A % OF NET SALES | | | | | | | | | | |
COST OF PRODUCTS SOLD | | | 47.6 | % | | 48.1 | % | | (50 | ) |
GROSS MARGIN | | | 52.4 | % | | 51.9 | % | | 50 | |
SELLING, GENERAL & ADMINISTRATIVE EXPENSE | | | 31.4 | % | | 31.5 | % | | (10 | ) |
OPERATING MARGIN | | | 21.1 | % | | 20.4 | % | | 70 | |
EARNINGS BEFORE INCOME TAXES | | | 20.1 | % | | 19.3 | % | | 80 | |
NET EARNINGS | | | 14.1 | % | | 13.5 | % | | 60 | |
Net sales fiscal year to date increased 14 percent to $57.20 billion behind 11 percent volume growth, including an additional three months of Gillette results during the current fiscal year to date period versus the comparable year ago period. Organic volume grew five percent with broad-based growth across the business. Every reportable segment delivered year-on-year organic volume growth driven by product initiatives including Tide Simple Pleasures, Febreze Noticeables, Pantene Color Expressions, Olay Regenerist and Definity and the Head & Shoulders and Herbal Essences restages. Price increases taken across several segments added one percent to sales growth while favorable foreign exchange trends had a positive two percent impact. Product mix had no net impact on sales growth as the favorable mix impact from the additional period of Gillette results was offset by disproportionate growth in developing regions, where unit selling prices are below the Company average. Organic sales increased six percent fiscal year to date.
| Net Sales Change Drivers 2007 vs. 2006 (Nine Months Ended March 31) |
| Volume with Acquisitions & Divestitures | Volume excluding Acquisitions & Divestitures | Foreign Exchange | Price | Mix/ Other | Net Sales Growth | Net Sales Growth ex-FX |
Beauty and Health | | | | | | | |
Beauty | 5% | 5% | 3% | 0% | 1% | 9% | 6% |
Health Care | 10% | 3% | 2% | 2% | 1% | 15% | 13% |
Household Care | | | | | | | |
Fabric Care and Home Care | 8% | 7% | 2% | 1% | 0% | 11% | 9% |
Baby Care and Family Care | 5% | 5% | 2% | 1% | (1)% | 7% | 5% |
Snacks, Coffee and Pet Care | 1% | 1% | 1% | 1% | 1% | 4% | 3% |
Gillette GBU | | | | | | | |
Blades and Razors | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Duracell and Braun | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Company | 11% | 5% | 2% | 1% | 0% | 14% | 12% |
Sales percentage changes are approximations based on quantitative formulas that are consistently applied.
Gross margin increased 50-basis points for the fiscal year to date period to 52.4% of net sales. Higher commodity costs had a negative gross margin impact of approximately 80-basis points. Scale leverage from organic volume growth, price increases and cost savings projects more than offset the commodity cost increase. The mix benefit of an additional three months of Gillette in the current fiscal year to date period added approximately 40-basis points due to higher average margins in the Blades and Razors segment.
Total selling, general and administrative expenses (SG&A) increased 13%, or $2.10 billion fiscal year to date. The additional three months of Gillette in the current fiscal year to date period accounted for approximately $1.08 billion of the SG&A increase, including approximately $160 million of incremental acquisition-related expenses. The acquisition-related expenses are primarily comprised of increased intangible asset amortization resulting from revaluing intangible assets in the opening balance sheet of the acquired Gillette business and integration-related expenses. Total SG&A as a percentage of net sales decreased by 10-basis points as lower overhead spending as a percentage of net sales on our base business (excluding Gillette) driven by volume scale leverage, overhead cost control and synergies from the Gillette integration activities more than offset the impact of higher acquisition-related expenses.
Interest expense fiscal year to date increased by $157 million versus the prior year period. The increase was driven by the financing cost of debt issued to fund the share repurchase program associated with the Gillette acquisition. The share repurchase program was completed during the first quarter of the fiscal year. We repurchased $20.1 billion of shares under the program since its inception.
Other non-operating income increased during the fiscal year to date period by $208 million versus the base year period primarily as a result of the gains on certain minor Beauty divestitures including Pert in North America and Sure, as well as higher interest income.
Net earnings increased 19 percent to $8.07 billion behind organic sales growth, the impacts from the addition of Gillette, including financing and other acquisition-related expenses, and profit margin expansion. Diluted net earnings per share were $2.37, up 13 percent versus the prior year. Earnings per share growth lagged net earnings growth due to a net increase in the weighted average shares outstanding in the current year to date period (incremental shares issued in conjunction with the Gillette acquisition on October 1, 2005, net of share repurchases, primarily under the Gillette repurchase program).
BUSINESS SEGMENT DISCUSSION- Three and Nine Months Ended March 31, 2007
The following discussion provides a review of results by business segment. Analyses of the results for the three and nine months ended March 31, 2007 are provided compared to the same three and nine month period ended March 31, 2006. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales and net earnings by business segment for the three and nine months ended March 31, 2007 versus the comparable prior year period (Amounts in millions):
| Three Months Ended March 31, 2007 | |
| Net Sales | | % Change Versus Year Ago | | Earnings Before Income Taxes | | % Change Versus Year Ago | | Net Earnings | | % Change Versus Year Ago | |
Beauty | $ | 5,620 | | | 8 | % | $ | 1,112 | | | 7 | % | $ | 805 | | | 9 | % |
Health Care | | 2,189 | | | 10 | % | | 529 | | | 36 | % | | 347 | | | 31 | % |
Beauty and Health | | 7,809 | | | 8 | % | | 1,641 | | | 15 | % | | 1,152 | | | 15 | % |
| | | | | | | | | | | | | | | | | | |
Fabric Care and Home Care | | 4,738 | | | 12 | % | | 1,031 | | | 22 | % | | 685 | | | 21 | % |
Baby Care and Family Care | | 3,268 | | | 10 | % | | 606 | | | 15 | % | | 382 | | | 17 | % |
Snacks, Coffee and Pet Care | | 1,090 | | | 0 | % | | 191 | | | (5 | )% | | 116 | | | (3 | )% |
Household Care | | 9,096 | | | 10 | % | | 1,828 | | | 16 | % | | 1,183 | | | 17 | % |
| | | | | | | | | | | | | | | | | | |
Blades and Razors | | 1,284 | | | 8 | % | | 405 | | | 12 | % | | 294 | | | 11 | % |
Duracell and Braun | | 789 | | | 3 | % | | 29 | | | (62 | )% | | 18 | | | (67 | )% |
Gillette GBU | | 2,073 | | | 6 | % | | 434 | | | (1 | )% | | 312 | | | (2 | )% |
| | | | | | | | | | | | | | | | | | |
Total Business Segments | | 18,978 | | | 9 | % | | 3,903 | | | 13 | % | | 2,647 | | | 13 | % |
Corporate | | (284 | ) | | N/A | | | (367 | ) | | N/A | | | (135 | ) | | N/A | |
Total Company | | 18,694 | | | 8 | % | | 3,536 | | | 13 | % | | 2,512 | | | 14 | % |
| Nine Months Ended March 31, 2007 | |
| Net Sales | | % Change Versus Year Ago | | Earnings Before Income Taxes | | % Change Versus Year Ago | | Net Earnings | | % Change Versus Year Ago | |
Beauty | $ | 17,107 | | | 9 | % | $ | 3,644 | | | 11 | % | $ | 2,685 | | | 13 | % |
Health Care | | 6,771 | | | 15 | % | | 1,772 | | | 25 | % | | 1,204 | | | 25 | % |
Beauty and Health | | 23,878 | | | 11 | % | | 5,416 | | | 15 | % | | 3,889 | | | 17 | % |
| | | | | | | | | | | | | | | | | | |
Fabric Care and Home Care | | 14,172 | | | 11 | % | | 3,142 | | | 14 | % | | 2,112 | | | 14 | % |
Baby Care and Family Care | | 9,486 | | | 7 | % | | 1,754 | | | 13 | % | | 1,106 | | | 13 | % |
Snacks, Coffee and Pet Care | | 3,406 | | | 4 | % | | 567 | | | 14 | % | | 353 | | | 15 | % |
Household Care | | 27,064 | | | 8 | % | | 5,463 | | | 14 | % | | 3,571 | | | 14 | % |
| | | | | | | | | | | | | | | | | | |
Blades and Razors | | 3,865 | | | 65 | % | | 1,272 | | | 73 | % | | 932 | | | 74 | % |
Duracell and Braun | | 3,112 | | | 52 | % | | 492 | | | 54 | % | | 331 | | | 51 | % |
Gillette GBU | | 6,977 | | | 59 | % | | 1,764 | | | 67 | % | | 1,263 | | | 67 | % |
| | | | | | | | | | | | | | | | | | |
Total Business Segments | | 57,919 | | | 14 | % | | 12,643 | | | 20 | % | | 8,723 | | | 21 | % |
Corporate | | (715 | ) | | N/A | | | (1,141 | ) | | N/A | | | (651 | ) | | N/A | |
Total Company | | 57,204 | | | 14 | % | | 11,502 | | | 19 | % | | 8,072 | | | 19 | % |
BEAUTY AND HEALTH
Beauty
Beauty net sales were up eight percent during the quarter to $5.62 billion. Volume increased three percent with organic volume up four percent. Volume growth was driven by double-digit growth in skin care and prestige fragrances and high-single digit growth in feminine care behind Olay Regenerist, Olay Definity, Dolce & Gabbana and Hugo Boss and Always. Hair care organic volume was up mid-single digits behind Head & Shoulders and Herbal Essences growth. Volume growth in these categories was partially offset by softness in the balance of the categories and the impact of the divestiture of several minor brands including Pert in North America and Sure. Volume and sales growth were also negatively impacted by lower sales on SK-II as the brand continues to recover from prior period business disruptions in Asia. Carryover price increases, primarily in feminine care, contributed one percent to sales growth. Positive product mix from disproportionate prestige fragrance growth added an additional one percent to sales growth. Foreign exchange had a positive three percent impact on net sales. Organic sales increased five percent. Net earnings in Beauty were up nine percent to $805 million behind sales growth. Earnings margin was roughly in-line with the prior year period as higher marketing spending as a percentage of net sales was largely offset by the impact of divestiture gains on minor Beauty brands.
Beauty fiscal year to date net sales increased nine percent to $17.11 billion. Both unit volume and organic volume increased five percent for the period. Skin care volume was up high-single digits behind Olay Definity and Regenerist. Hair care volume increased mid-single digits driven by product initiatives on Pantene, Head & Shoulders and Herbal Essences. Feminine care volume increased mid-single digits due to market share growth on Always and Tampax behind the Always Clean and Fresh initiatives and product upgrades on Tampax Pearl. Prestige fragrances volume increased double-digits behind the Dolce and Gabbana “The One” launch. Disproportionate growth in prestige fragrances had a positive mix impact of one percent on sales growth while favorable foreign exchange had a three percent impact. Beauty organic sales were up five percent fiscal year to date, including a negative impact from the sales disruption in Asia resulting from the temporary suspension of SK-II shipments in China. Net earnings increased 13 percent to $2.69 billion behind sales growth and earnings margin improvement. Earnings margin increased 60-basis points due to divestiture gains on minor Beauty brands and lower SG&A as a percent of sales, partially offset by the impact of the SK-II disruption. SG&A as a percent of sales improved as the scale benefits of volume growth and lower overhead spending as a percentage of net sales more than offset higher marketing spending as a percentage of net sales.
Health Care
Health Care net sales increased 10 percent to $2.19 billion during the quarter behind six percent volume growth. Oral care volume was up mid-single digits, driven by double-digit growth in developing regions behind market share gains. Pharmaceuticals and personal health care volume was up mid-single digits as growth on Prilosec OTC and Vicks more than offset softness in pharmaceuticals. Prilosec OTC volume increased double-digits behind a two point increase in U.S. market share and a base period that was depressed due to customer inventory builds ahead of a prior period price increase. Price increases, primarily in pharmaceuticals and personal health care, added one percent to sales growth while a more premium product mix added an additional one percent. Favorable foreign exchange had a two percent impact on net sales. Health Care net earnings grew 31 percent to $347 million during the quarter behind sales growth and higher earnings margin. Earnings margin improved 260-basis points for the quarter behind volume scale leverage, lower product costs, Gillette synergy savings and lower research and development costs in our pharmaceuticals business driven by the timing of clinical milestone payments.
Health Care net sales were $6.77 billion fiscal year to date, up 15 percent versus the comparable prior year period on 10 percent volume growth. Sales and volume increased as a result of three additional months of Gillette oral care results in the current fiscal year period and growth on the base P&G business. Health Care organic sales increased six percent fiscal year to date behind three percent organic volume growth. Oral care organic volume grew mid-single digits driven by high-single digit growth in developing regions behind market share gains. Pharmaceuticals and personal health volume increased low-single digits behind growth on Prilosec OTC and Vicks. Pricing, primarily in pharmaceuticals and personal health, contributed two percent to segment sales growth while a more premium product mix added an additional one percent. Foreign exchange had a positive two percent impact on net sales. Net earnings grew 25 percent fiscal year to date to $1.20 billion behind organic sales growth, the addition of Gillette oral care and earnings margin expansion. Earnings margin increased 140-basis points as lower SG&A as a percent of sales and lower product costs more than offset the negative mix impact on gross margin from the addition of the Gillette oral care business. SG&A improved as a percentage of net sales due to volume scale leverage, lower research and development costs in our pharmaceuticals business driven by the timing of clinical milestone payments and Gillette synergy savings.
HOUSEHOLD CARE
Fabric Care and Home Care
Fabric Care and Home Care net sales increased 12 percent during the quarter to $4.74 billion driven by a 10 percent increase in unit volume. Volume growth was balanced across both the fabric care and the home care businesses and across all regions. Each geographic region delivered high-single digit or above volume growth. Key brands drove the growth with Tide, Ariel, Downy, Swiffer and Cascade each posting double-digit volume growth for the quarter. Favorable foreign exchange added two percent to sales growth. Net earnings increased 21 percent during the quarter to $685 million behind sales growth and a 110-basis point earnings margin expansion from lower SG&A as a percentage of net sales. SG&A benefited from lower overhead and marketing spending as a percentage of net sales. Manufacturing cost savings, volume scale leverage and cost savings initiatives offset higher commodity costs.
Fabric Care and Home Care fiscal year to date net sales increased 11 percent to $14.17 billion behind eight percent volume growth. Volume growth was broad-based across regions with mid-single digit increases in developed regions and double-digit growth in developing regions. Both fabric care and home care grew volume high-single digits behind product initiatives such as Tide Simple Pleasures, Gain Joyful Expressions, Febreze Noticeables, upgrades on Swiffer and the launch of Fairy auto-dishwashing in Western Europe. The impact of previously executed price increases added one percent to sales growth while favorable foreign exchange had a positive two percent impact. Net earnings increased 14 percent to $2.11 billion behind sales growth and a 50-basis point improvement in net earnings margin. Earnings margin improved behind lower overhead expenses as a percentage of net sales. Scale benefits of volume growth and cost savings projects offset higher commodity costs.
Baby Care and Family Care
Baby Care and Family Care net sales increased 10 percent to $3.27 billion during the quarter behind eight percent unit volume growth. Baby care volume was up high-single digits, led by double-digit growth in developing regions behind market share growth. In developed regions, baby care volume increased mid-single digits, driven largely by the Caterpillar stretch initiative on Pampers Baby Dry in North America and Western Europe. Family care volume increased high-single digits behind product performance improvements on Bounty and continued growth on Bounty Basics and Charmin Basics. Pricing in North America family care added one percent to segment sales growth. Disproportionate growth in developing regions and on the Basics products, which have lower average selling prices, drove a negative two percent mix impact. Favorable foreign exchange added three percent to sales. Net earnings in Baby Care and Family Care increased 17 percent during the quarter to $382 million behind sales growth and a 70-basis point increase in earnings margin. The earnings margin expansion was driven by lower SG&A from reduced marketing and overhead spending as a percentage of net sales. Volume scale leverage and manufacturing cost savings projects largely offset the impact of higher pulp costs.
Baby Care and Family Care net sales increased seven percent fiscal year to date to $9.49 billion behind five percent volume growth. Baby care volume increased mid-single digits with developing regions up double-digits. In developed regions, baby care volume was up low-single digits as growth on Pampers Baby Stages of Development and Caterpillar stretch more than offset softness on Pampers in Western Europe and Luvs in North America from lower competitor pricing of both branded and private label products. Family care volume increased low-single digits globally. Family care organic volume was up mid-single digits behind product performance improvements on Bounty and continued growth on Bounty Basics and Charmin Basics. Price increases in North America family care added one percent to sales growth while disproportionate growth in developing regions and on the Basics products led to a negative one percent mix impact. Favorable foreign exchange added two percent to sales growth. Net earnings in Baby Care and Family Care increased 13 percent fiscal year to date to $1.11 billion behind sales growth and a 70-basis point improvement in net earnings margin. Earnings margin expansion was driven by lower overhead and marketing expenses as a percentage of net sales. Manufacturing cost savings and volume scale leverage offset the impact of higher pulp costs.
Snacks, Coffee and Pet Care
Snacks, Coffee and Pet Care net sales were in-line with the prior year period at $1.09 billion. Volume was down two percent during the quarter as high-single digit growth in snacks was more than offset by the impacts of a reduction in coffee trade inventory and a pet food recall. In coffee, U.S. market share on Folgers was up one point versus the prior year period. However, volume was down primarily due to lower year-on-year trade inventory levels. Trade inventory levels decreased during the current quarter due to the impact of a January price increase on Folgers coupled with heavy competitive promotion activity. Pet care volume declined due to strong competitive activity and the impacts of a voluntary pet food recall of some Iams and Eukanuba wet pet foods in March. Snacks volume increased behind the Pringles Select and Minis initiatives. Pricing contributed three percent to segment net sales growth following a January price increase on Folgers. Disproportionate growth in snacks, which has a lower selling price than the segment average, resulted in a negative two percent mix impact. Favorable foreign exchange added one percent to sales. Net earnings were down three percent to $116 million during the quarter as higher commodity costs across the segment and expenses associated with the pet food recall more than offset the base period impacts related to Hurricane Katrina and an additional insurance recovery from Katrina in the current period.
Snacks, Coffee and Pet Care net sales increased four percent fiscal year to date to $3.41 billion. Volume was up one percent as growth in coffee was largely offset by a decline in pet care and flat volume in snacks. Coffee volume was up high-single digits primarily due to a weak base period that included a reduction in the coffee business from Hurricane Katrina and current period volume from the recent launches of Folgers Simply Smooth and Gourmet Selections. Pet care volume was down versus the year-ago period due to strong competitive activity and the impacts of a voluntary pet food recall of the Iams and Eukanuba wet pet foods in March 2007. Price increases in coffee, product mix from disproportionate coffee growth and foreign exchange each had a positive one percent impact on sales. Net earnings increased 15 percent to $353 million fiscal year to date. Earnings increased primarily due to base period impacts related to Hurricane Katrina, which more than offset the impacts of higher commodity costs and expenses associated with the pet food recall in the current period.
GILLETTE GBU
As disclosed in Note 4 to the consolidated financial statements, we completed the acquisition of The Gillette Company on October 1, 2005. This acquisition resulted in two new reportable segments for the Company: Blades and Razors and Duracell and Braun. The Gillette oral care and personal care businesses were subsumed within the Health Care and Beauty reportable segments, respectively. Because the acquisition was completed in October 2005, there are no results for these segments in our base July-September 2005 period.
In order to provide our investors with more insight into the results of the Blades and Razors and Duracell and Braun reporting segments, we have previously provided supplemental pro forma net sales and earnings data for these segments for the quarter ended September 30, 2005 (as presented in our Form 8-K released November 22, 2005). Management’s discussion of the current quarter results is in relation to the comparable prior year reported net sales and net earnings results. The fiscal year to date results of these two segments is in relation to comparable prior year results including pro forma net sales and earnings data for the July - September 2005 period and reported results for the October 2005 - March 2006 period. With respect to the earnings data, the fiscal year to date analysis is based on earnings before income taxes. The previously disclosed Blades and Razors and Duracell and Braun pro forma information reconciled “Profit from Operations,” the measure used by Gillette in its historical filings, to Earnings before Income Taxes, the comparable measure used by the Company. Gillette did not allocate income tax expense to its reporting segments.
Blades and Razors
Net sales in Blades and Razors increased eight percent to $1.28 billion behind four percent volume growth. In developing regions, volume increased high-teens behind double-digit growth on Mach 3. Volume in developed regions was down due to the base period launch of Fusion in North America, the segment’s largest region. Current period volume did benefit from continued expansion of Fusion with current quarter launches in several European countries and in Australia. Pricing across most shaving systems contributed two percent to sales growth, while disproportionate growth in developing regions resulted in a negative two percent mix impact. Foreign exchange added four percent to sales growth. Net earnings were up 11 percent during the quarter to $294 million behind sales growth and a 60-basis point increase in earnings margin. Earnings margin was up as gross margin expansion from a more favorable product mix driven by Fusion more than offset higher marketing and overhead expenses as a percentage of net sales. Overhead expenses increased year-on-year due to the inclusion of Gillette into P&G’s corporate allocations systems. This had no net impact on the Company’s total overhead expense as the offsetting reductions are spread across the Beauty and Health and the Household Care GBUs.
Net sales in Blades and Razors increased 10 percent fiscal year to date to $3.87 billion versus the comparable pro forma prior year period. Net sales increased primarily behind growth on Fusion in developed regions and on Mach 3 in developing regions. Overall, volume/mix contributed six percent to sales growth while price increases taken across most shaving systems added one percent. Favorable foreign exchange had a three percent impact on net sales. Earnings before income taxes increased 14 percent to $1.27 billion versus the comparable prior year pro forma results, including $65 million of incremental acquisition-related charges in the current fiscal year period. The incremental acquisition-related charges are comprised of amortization charges from revaluing intangible assets in the opening balance sheet, partially offset by base period product costs related to revaluing Gillette’s opening balance sheet inventory balance. Amortization charges are higher in the current fiscal year to date period due to the extra three months of Gillette post-acquisition results in the current period. Earnings growth was driven by sales growth and synergy savings, partially offset by higher marketing investment behind Fusion, higher overhead expenses and acquisition-related charges. Overhead expenses are up year-on-year due to the integration of the Gillette GBU into the Company’s corporate allocations systems in the current period. Net earnings were $932 million fiscal year to date.
Duracell and Braun
Net sales in Duracell and Braun increased three percent to $789 million. Unit volume for the segment was flat globally with organic volume up three percent. In Duracell, volume increased low-single digits driven by developing market growth. Developed market volumes were negatively impacted by high levels of competitive activity from both branded and private label competitors in North America and Western Europe. In Braun, unit volume was down globally as mid-single digit growth in developing regions was more than offset by the impact of the divestiture of thermometer and blood pressure devices. Braun organic volume increased mid-single digits behind the 360 Complete, Pulsonic and Contour male shavers. Price increases on Duracell contributed two percent to segment sales growth but were offset by a negative two percent mix impact driven in part by disproportionate growth in developing regions. Favorable foreign exchange added three percent to sales growth. Net earnings declined $36 million during the quarter to $18 million. Earnings were down primarily due to higher zinc costs and higher overheads resulting from the inclusion of Gillette into P&G’s corporate allocations systems. This had no net impact on the Company’s total overhead expense as the offsetting reductions are spread across the Beauty and Health and the Household Care GBUs.
Net sales in Duracell and Braun increased five percent fiscal year to date to $3.11 billion versus the comparable prior year pro forma results. In Duracell, sales increased mid-single digits globally, led by double-digit growth in developing regions. In developed regions, Duracell organic sales were in-line with the prior year period due to high levels of competitive activity from both private label and branded competitors. In Braun, sales increased mid-single digits as the launch of 360 Complete and Contour razors in North America and Pulsonic razors in Germany and Japan more than offset softness in Western Europe household appliances, lower year-on-year winter holiday promotion activity in North America and the divestiture of thermometer and blood pressure devices. Overall, volume/mix in the Duracell and Braun segment contributed two percent to sales growth while favorable foreign exchange added three percent. Earnings before income taxes increased four percent fiscal year to date to $492 million versus the comparable prior year period pro forma results. Earnings were up behind sales growth and lower year-on-year acquisition-related expenses, partially offset by higher overhead expenses. Acquisition-related charges were down primarily due to base period product costs related to revaluing Gillette opening balance sheet inventory level, which more than offset the impact of an additional three months of amortization charges in current year period from revaluing intangible assets in the opening balance sheet. Overhead expenses as a percentage of net sales increased year-on-year due to the integration of the Gillette GBU into the Company's corporate allocations systems in the current period. Net earnings were $331 million fiscal year to date.
Corporate
Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level, financing and investing activities, certain restructuring charges, other general corporate items and the historical results of certain divested brands, including certain Gillette brands that were divested in fiscal 2006 as required by the regulatory authorities in relation to the Gillette acquisition. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Because both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Company’s effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority interest.
Net earnings for the quarter were roughly in-line versus the prior year period. A curtailment gain resulting from the harmonization of U.S. postretirement income benefits between Gillette and P&G and lower interest expense were offset by the write-down of certain overhead-related manufacturing assets and a favorable legal settlement in the base period.
Net earnings for the fiscal year to date period were down $219 million primarily driven by increased interest expenses and higher restructuring and integration costs. Interest expense was up due to the financing costs of the share repurchase program announced in connection with the Gillette acquisition. The increase in restructuring expense is primarily related to costs incurred as part of the Gillette integration. These fiscal year to date cost increases were partially offset by the gains on the sale of certain minor brands including Pert in North America and Sure.
FINANCIAL CONDITION
Operating Activities
Cash generated fiscal year to date from operating activities was $9.85 billion versus $8.19 billion in the comparable prior year period. Net earnings, adjusted for non-cash items (primarily depreciation, amortization, share based compensation and deferred income taxes) provided $11.39 billion of operating cash. This was partially offset by an increase in working capital. Inventory was up primarily to support business growth and upcoming initiative launches. Accounts receivable increased due to business growth and continued temporary impacts related to the Gillette integration. Accounts payable was down as the Company continued its efforts to accelerate payments to suppliers in order to maximize payment discounts.
Investing Activities
Investing activities in the current year used $1.18 billion, compared to the prior year period cash use of $607 million. Acquisitions used $167 million of cash behind several small acquisitions versus a net source of cash of $216 million in the prior year period from net cash received in the Gillette acquisition, which more than offset funding related to the settlement of a major portion of the Wella Domination liability. Investment securities generated $725 million due to a shift from auction rate securities to cash equivalent securities. Capital expenditures were $2.00 billion, or 3.5 percent of net sales during the fiscal year to date period.
Financing Activities
Total cash used by financing activities was $11.53 billion fiscal year to date versus $5.36 billion in the comparable prior year period. We repurchased $4.06 billion of treasury shares and reduced our debt position by $5.61 billion in the current fiscal year to date period. In the prior year period, we repurchased $10.60 billion of treasury shares funded in part by increases in our debt position of $6.76 billion during the period.
As of March 31, 2007 the Company’s current liabilities exceeded current assets by $8.21 billion. The key driver was the refinancing of a portion of our long-term credit facility with commercial paper. The Company anticipates being able to support its short-term liquidity through cash generated from operations. The Company also has very strong long- and short-term debt ratings which will enable it to continue to refinance this debt at favorable rates in commercial paper and bond markets. In addition, the Company has agreements with a diverse group of creditworthy financial institutions that, if needed, would provide sufficient credit funding to meet short-term financing requirements.
RECONCILIATION OF NON-GAAP MEASURES
Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion.
Organic Sales Growth. Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the January - March quarter:
| | Total Company | | Beauty | |
Total Sales Growth | | | 8 | % | | 8 | % |
Less: Foreign Exchange Impact | | | (2 | )% | | (3 | )% |
Less: Acquisition/Divestiture Impact | | | 0 | % | | 0 | % |
Organic Sales Growth | | | 6 | % | | 5 | % |
The reconciliation of reported sales growth to organic sales for the fiscal year to date period:
| | Total Company | | Beauty | | Health Care | |
Total Sales Growth | | | 14 | % | | 9 | % | | 15 | % |
Less: Foreign Exchange Impact | | | (2 | )% | | (3 | )% | | (2 | )% |
Less: Acquisition/Divestiture Impact | | | (6 | )% | | (1 | )% | | (7 | )% |
Organic Sales Growth | | | 6 | % | | 5 | % | | 6 | % |
Free Cash Flow. Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation.
Free Cash Flow Productivity. Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Company’s long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions):
| Operating Cash Flow | | Capital Spending | | Free Cash Flow | | Net Earnings | | Free Cash Flow Productivity |
Jul - Mar ’07 | $9,853 | | $(1,996) | | $7,857 | | $8,072 | | 97% |